National Cancer Awareness Day

▴ National Cancer Awareness Day
The Most Common Types of Cancer in India Include: Breast Cancer, Cervical Cancer and Oral Cancer.

     National Cancer Awareness Day is observed in India on 7th November every year. The day is significant as it instructs individuals about the genuine danger of cancer. As per the World Health Organization (WHO), the disease is the subsequent driving reason for death worldwide. In 2018, roughly 18 million cases were there internationally, of which, 1.5 million were in India alone. In 2018, there were around 0.8 million cancer deaths in India against 9.5 million universally. By 2040, the number of new cases is assessed to be twofold in India.


The Most Common Types of Cancer in India Include: Breast Cancer, Cervical Cancer and Oral Cancer.


The extended rate of patients In India, according to Cancer Statistics, 2020: Report from National Cancer Registry program, among males was 679,421 (94.1 per 100,000) and among females 712,758 (103.6 per 100,000) for the year 2020. One out of 68 males (lung cancer), 1 out of 29 females (breast cancer), and 1 out of 9 Indians will develop cancer during their lifetime (0-74 years old).


India launched a disease control program in 1976, yet there are insufficient assets in light of the fact that the government spends a simple 1.2% of GDP on medical services or healthcare. In any case, at some point this year, the government plans to dispatch free cancer screening for oral, breast, and cervical cancer in 165 of the nation's 700 areas.


Some facts:

Tobacco chewing has been legitimately connected to cancer, prompting most deaths in the year 2018. While males are inclined to death by cancer of the cavity and lungs, females could die of breast cancer and oral cavity cancer. A female dies of cervical cancer every 8 minutes.


While it is prudent to go through a screening to identify cancer growth, here are a couple of indications that may raise caution.

Diarrhea Consistent cough and blood in spit Unexplained iron deficiency Breast knots Change in pee or color Blood in stool


Treatment for Cancer:

National Pharmaceutical Pricing Authority (NPPA) dispatched Pilot on Trade Margin Rationalization for 42 against cancer drugs. The activity was taken to make the treatment moderate to the average person.

Different treatments for Cancer are:

Immunotherapy Chemotherapy Radiation Therapy Hormone Therapy Targeted Therapy Stem Cell Transplant Surgery Precision Medicine


Prevention for Cancer:

Having a healthy eating routine Appropriate weight Get immunized Sun Protection Don't utilize tobacco Regular checks


What is harder to clarify is the reason more females in India are determined to have cancer growth than males, as per another investigation distributed in The Lancet Oncology. Males report a 25% higher occurrence of disease than females everywhere in the world, yet India avoids this pattern. Having said that, a larger number of males die of cancer in India than females. However, that is on the grounds that breast, cervical, ovarian, and uterine cancer, which represent over 70% of the tumors in females in India, permit higher odds of endurance on treatment. Indian males experience the ill effects of lung or oral cancer growth - both identified with smoking and ingesting tobacco - which is more harmful with lower endurance rates.


Breast cancer is presently the most well-known disease among females in India, representing 27% of all tumors among females. Oncologists’ state there has been a sharp uptick in cases over the most recent six years.


At 45-50 years, the pinnacle period of the beginning of breast - and ovarian cancer - in India gives off an impression of being 10 years more youthful than the pinnacle age (over 60 years) in developed nations. This could be because of hereditary and environmental elements.


Cancer is, on occasion, a genomic disease. Studies have demonstrated the BRCA1 and BRCA2 qualities as a rule increment a female’s danger of breast cancer growth four to eightfold and can clarify why a few families have loads of family members determined to have breast disease.

Be that as it may, under 10% of the breast cancer growths in India are acquired, so genomic screening may not be extremely valuable to discover the reason in by far most of female diseases.


National Institute of Cancer Prevention and Research realizes that the dangerous factors for breast cancer growth are:

Quickly urbanizing country High-fat eating routine Overweight Late marriage Fewer children Insufficient breastfeeding Absence of awareness Hesitance to go to specialists


The main silver coating as per the oncologists is that 60% of those with breast cancer growth in India survive for five years.

Tags : #medicircle #cancer #nationalcancerawarenessday #cancerawarenessday #preventionofcancer #treatmentofcancer #cancerindia #breastcancer #cervicalcancer #oralcancer

About the Author

Rabia Mistry Mulla

'For vessels to change their course, they have to be hit by a strong wind first!'
So here I am penning down my thoughts on health and research after 6 years of planning Diets.
Being a Clinical Dietitian & a Diabetes Educator I always had a thing for writing, alas, been hit by the winds towards a new course!
You can write to me at [email protected]

Related Stories

Loading Please wait...

Trending Now

1,031 new cases of COVID-19 confirmed in Himachal PradeshNovember 25, 2020
Cooking with wood may cause lung damageNovember 25, 2020
More than 56 lakh sample tests for COVID-19 conducted in OdishaNovember 25, 2020
COVID-19 recovery rate in Bihar improves to 97.30 pctNovember 25, 2020
Green Mediterranean (‘green Med’) diet may be even better for healthNovember 25, 2020
Chhattisgarh: Intensive Covid screening of all passengers to be done mandatorily at airportsNovember 25, 2020
New guidance issued on policies to protect populations in vulnerable situations in context of COVID-19November 25, 2020
Life Extension® Launches Bloat Relief Formula.November 25, 2020
Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin Lab Client to Support COVID-19 PCR TestingNovember 25, 2020
Bristol Myers Squibb Receives European Commission Approval for OpdivoNovember 25, 2020
QualTex Laboratories adds Ortho Diagnostics VITROS® Anti-SARS-CoV-2 IgG assayNovember 25, 2020
China resorts to rigorous measures after multiple locally transmitted coronavirus cases detected in three citiesNovember 25, 2020
National COVID-19 recovery rate reaches 93.72 pctNovember 25, 2020
Nearly 11,60,000 COVID samples tested in country in last 24 hoursNovember 25, 2020
Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysisNovember 25, 2020
Taking the Pill may cut risk of severe asthma bouts in women of reproductive ageNovember 25, 2020
Multilateral cooperation is key to overcoming global challenges such as COVID-19: Dr Harsh VardhanNovember 25, 2020
Polaryx Therapeutics receives both rare pediatric disease and orphan drug designations from US FDANovember 25, 2020
Panaxia and Neuraxpharm expand strategic collaboration to France with medical cannabisNovember 25, 2020
6,224 new cases of COVID-19 detected in DelhiNovember 25, 2020